Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings
07/02/2024 12:51
Feb 7 (Reuters) - Remus Pharmaceuticals Ltd REMP.NS :
* ACQUIRING MEMBERSHIP INTEREST OF 56.67% IN ESPEE GLOBAL
HOLDINGS
* APPROVED SETTING UP OF A BRANCH OFFICE IN DUBAI
* ESPEE DEAL FOR $ 2.7 MILLION
Source text for Eikon: ID:nNSE5csCmR
Further company coverage: REMP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Remus Pharmaceuticals
See all newsBrief: Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings
Brief: Remus Pharmaceuticals To Sell Entire Stake In Unit Ratnatris Pharmaceuticals Via Shares Swap
Brief: Remus Pharmaceuticals To Make Strategic Investment In Espee Biopharma & Finechem LLC